Superpower
Superpower is a startup that offers personalized, preventative health care in the United States, with lab testing and AI-generated health overviews.
Who it reaches
People in the United States who want personalized, preventative and longevity-focused medicine, with twice-yearly lab testing and a personal health plan.
Superpower funding rounds
Key facts
- Founded
- 2023, in San Franciscosource
- Series A
- $30 million, reported April 2025source
- Pre-seed
- $4 million, led by Susa Ventures, May 2024source
- Chief executive
- Jacob Peters, as of May 2024source
- Peptide sales
- Selling legally available peptides and subscription biomarker testing to members as of January 2024source
- Valuation reported
- more than $300 million, April 2025source
- App price (US)
- US$499 a yearsource
- Peptide launch
- Opened pre-orders on October 30, 2026 for BPC-157 and TB-500 at $149 a month and MOTS-c at $199 a month, with a target ship date of late Novembersource
- Peptide status
- Its page says compounded BPC-157 is not FDA-approved and that the HHS policy it relies on is not FDA approvalsource
WYDE coverage of Superpower
WYDE Newsroom has published 3 articles about Superpower, from Oct 27, 2026 to Oct 31, 2026. Superpower is the subject of 3 stories. The most recent is Last Day to Apply: The $1 Million Creator Fund Closes Tonight.
Last Day to Apply: The $1 Million Creator Fund Closes Tonight
WYDE Weekly: EAT's $1 million clipping fund closes tonight at 11:59 p.m. Pacific. Plus 33 countries on stockpiling food, WFP's Gaza cuts, a prank that became a $605,350 GoFundMe, $200 million for Boston Children's and the $6.3 billion Binance hack.
Oct 31, 2026 · 8 min read · Subject of the story
HealthcareSuperpower Opens $149-a-Month BPC-157 Pre-Orders Two Days After HHS Eased Peptide Enforcement
Superpower will charge $149 a month for compounded BPC-157 and TB-500 and $199 for MOTS-c, shipping in late November. FDA's drug center recommended against listing all three, and the policy allowing the sales is not FDA approval.
Oct 30, 2026 · 4 min read · Subject of the story
HealthcareSuperpower's 152-Peptide Library Includes BPC-157, Which FDA Proposed Keeping Off the 503A Bulks List
Superpower announced its 152-peptide library on X on October 26, 2026. Its BPC-157 entry notes a July advisory vote in favor of compounding, while FDA's own briefing proposed against listing the peptide.
Oct 27, 2026 · 4 min read · Subject of the story
Reported alongside Superpower
- Binance · in 1 story with Superpower
- Boston Celtics · in 1 story with Superpower
- Boston Celtics Shamrock Foundation · in 1 story with Superpower
- Boston Children's Hospital · in 1 story with Superpower
- Centre College · in 1 story with Superpower
- GoFundMe · in 1 story with Superpower
- Met Council · in 1 story with Superpower
- OpenAI · in 1 story with Superpower
Sources
- Silicon UK: Superpower Raises $4M Pre-Seed to Launch Preventative Healthcare Platform
- Athletech News: Superpower Raises $30M To Redefine Preventative Care
- SmartCompany: Superpower raises $47 million to help people live longer
- Let's Data Science: Superpower Sells Peptides Following Looser Oversight (March 22, 2026)
Track the institutions that move money.
Data-driven coverage, every week.